MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Vandetanib hydrochloride

CAS No. : 524722-52-9

MCE 站：Vandetanib hydrochloride

产品活性：Vandetanib hydrochloride (D6474 hydrochloride) 是一种有效的，具有口服活性的 VEGFR2/KDR 酪氨酸激酶抑制剂 (IC₅₀=40 nM)。Vandetanib hydrochloride 也抑制 VEGFR3/FLT4 (IC₅₀=110 nM) 和 EGFR/HER1 (IC₅₀=500 nM)。

研究领域：Protein Tyrosine Kinase/RTK  |  Autophagy  |  Apoptosis

作用靶点：VEGFR  |  Autophagy  |  Apoptosis

In Vitro: Vandetanib inhibits VEGFR3 ａnd EGFR with IC₅₀ of 110 nM ａnd 500 nM, respectively. Vandetanib is not sensitive to PDGFRβ, Flt1, Tie-2 ａnd FGFR1 with IC₅₀ of 1.1-3.6 μM, while almost has no activity against MEK, CDK2, c-Kit, erbB2, FAK, PDK1, Akt ａnd IGF-1R with IC₅₀ above 10 μM. Vandetanib inhibits VEGF-, EGF- ａnd bFGF-stimulated HUVEC proliferation with IC₅₀ of 60 nM, 170 nM ａnd 800 nM, with no effect on basal endothelial cell growth. Vandetanib inhibits tumor cell growth with IC₅₀ of 2.7 μM (A549) to 13.5 μM (Calu-6). Odanacatib is a weak inhibitor of antigen presentation, measured in a mouse B cell line (IC₅₀=1.5±0.4 μM), compared to the Cat S inhibitor LHVS (IC₅₀=0.001 μM) in the same assay. Odanacatib also shows weak inhibition of the processing of the MHC II invariant chain protein Iip10 in mouse splenocytes compared to LHVS (minimum inhibitory concentration 1-10 μM versus 0.01 μM, respectively). Vandetanib suppresses phosphorylation of VEGFR-2 in HUVECs ａnd EGFR in hepatoma cells ａnd inhibits cell proliferation.

In Vivo: Vandetanib (15 mg/kg, p.o.) has a superior anti-tumor effect than gefitinib in the H1650 xenograft model, ａnd suppresses tumor growth with IC₅₀ of 3.5±1.2 μM. In tumor-bearing mice, vandetanib (50 or 75 mg/kg) suppresses phosphorylation of VEGFR-2 ａnd EGFR in tumor tissues, significantly reduces tumor vessel density, enhances tumor cell apoptosis, suppresses tumor growth, improves survival, reduces number of intrahepatic metastases, ａnd upregulates VEGF, TGF-α, ａnd EGF in tumor tissues.

相关产品：MG-132  |  LY294002  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Paclitaxel  |  Y-27632 dihydrochloride  |  Acetylcysteine  |  Angiotensin II human  |  SP600125  |  5-Fluorouracil  |  Staurosporine  |  Bortezomib  |  Tamoxifen  |  2-Deoxy-D-glucose  |  Gemcitabine  |  Verteporfin  |  Temozolomide  |  Decitabine  |  BAY 11-7082  |  Etoposide  |  CCCP  |  DAPT  |  Rote  |  Etomoxir  |  Docetaxel  |  Stattic  |  Fulvestrant  |  Everolimus  |  Resveratrol

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。